Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Emphysema Treatment Industry?

The size of the market for emphysema treatment has been progressively expanding in the past few years. It’s projected that this growth will progress from $5.15 billion in 2024 to $5.4 billion in 2025, representing a compound annual growth rate (CAGR) of 5.0%. The expansion during the historic period can be accredited to factors like the impact of the smoking epidemic, progress in medicinal treatments, the implementation of pulmonary rehabilitation programs, enhancement in diagnostic tools, as well as increased awareness and education.

A significant increase is expected to be noted in the size of the emphysema treatment market in the coming years. It is projected to expand to “$7.28 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. Several factors, such as the aging population, personalized treatment methods, improved access to treatments, emphasis on managing symptoms, and cooperative healthcare systems, contribute to this predicted growth. Key emerging patterns within the forecast period encompass the development of gene therapy, patient knowledge and empowerment, the introduction of artificial intelligence (AI), enhanced treatment accessibility, and development of long-acting drugs.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10807&type=smp

What Forces Are Driving The Growth Of The Emphysema Treatment Industry?

The growing number of chronic obstructive pulmonary disease (COPD) cases is anticipated to boost the emphysema treatment market’s expansion in the future. COPD is a collection of ailments that impede airflow and cause breathing difficulties, which includes conditions like emphysema and chronic bronchitis. Treatments for emphysema are crucial in slowing down the progression of COPD because they concentrate on symptom management, lung function restoration, and disease advancement delay. For example, the Australian Institute of Health and Welfare (AIHW) revealed in June 2024 that around 638,000 individuals in Australia, or 2.5% of the country’s population, were living with COPD in 2022. By 2023, COPD had accounted for 3.6% of the total disease burden, making up 50% of the respiratory conditions-related burden. Further, in 2022, COPD was the root cause of 7,691 deaths, translating to 29.6 deaths per 100,000 people and comprising 4.0% of all the country’s deaths. Thus, the increasing prevalence of COPD cases serves as a driving force for the expansion of the emphysema treatment market.

The emphysema treatment market covered in this report is segmented –

1) By Treatment: Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Surgery Transplant, Other Treatments

2) By Distribution Channel: Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies

3) By End-User: Clinics, Surgical Centre, Other End-Users

Subsegments:

1) By Smoking Cessation: Nicotine Replacement Therapy (NRT), Prescription Medications, Behavioral Therapy Programs

2) By Bronchodilators: Short-Acting Beta-Agonists (SABAs), Long-Acting Beta-Agonists (LABAs), Anticholinergics

3) By Steroids: Inhaled Corticosteroids (ICS), Oral Corticosteroids, Combination Inhalers

4) By Leukotriene Modifiers: Montelukast, Zafirlukast

5) By Supplemental Oxygen: Portable Oxygen Concentrators, Continuous Flow Oxygen Systems, Pulse Dose Oxygen Systems

6) By Antibiotics: Macrolides, Fluoroquinolones, Tetracyclines

7) By Gene Therapy: Gene Replacement Therapy, Antisense Oligonucleotides

8) By Surgery Transplant: Lung Volume Reduction Surgery (LVRS), Lung Transplantation

9) By Other Treatments: Pulmonary Rehabilitation Programs, Nutritional Support, Palliative Care

How Are Key Trends Driving Expansion In The Emphysema Treatment Industry?

Major businesses in the emphysema market are innovating minimally invasive techniques for patients suffering from emphysema as a way to gain a competitive advantage in the market. Minimally invasive procedures encompass medical actions or surgical operations that constrain the disruption to the body’s regular structures. For example, Adena Health System, a healthcare company from the United States, introduced the Zephyr Valve surgery in January 2022. This progressive procedure, designed as an alternative to the traditional lung volume reduction surgery, addresses the common issue of lung hyperinflation found in emphysema and COPD patients. This unique strategy involves inserting tiny Zephyr Valves into the air passages of the lungs using a bronchoscope. These valves play a critical role in expelling confined air, hindering future buildup, and facilitating the expansion of healthier areas of the lungs, thereby enhancing breathing.

Who Are The Primary Players Operating Across The Global Emphysema Treatment Market?

Major companies operating in the emphysema treatment market include AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Mylan N.V., Pfizer Inc., Orion Oyj, Verona Pharma PLC, Pulmonx Corporation, Emphasys Medical Inc., Halozyme Therapeutics Inc., Mariposa Health Limited, Uptake Technologies Inc., Respinova Ltd, Gala Therapeutics Inc., Pulmatrix Inc., Broncus Medical Inc., Holaira Inc., PneumRx Inc., Spiration Inc., Aeris Therapeutics Inc., CSA Medical Inc., Olympus Corporation

https://www.thebusinessresearchcompany.com/report/emphysema-treatment-global-market-report

Which Region Offers The Most Growth Potential For The Emphysema Treatment Market Through 2029?

North America was the largest region in the emphysema treatment market in 2024. The regions covered in the emphysema treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10807&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model